University of Virginia
Charlottesville, Virginia, United States
Purpose
to facilitate testing of candidate therapies for secretory diarrhea by producing a mouse model infected with a bacterium genetically engineered to express a toxin from Escherichia coli, which is a common cause of moderate to severe diarrhea.
Division
Global Health
Date
April 2014
Region Served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
19
Grantee location
Charlottesville, Virginia, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.